Improving the use of the HPV vaccine in primary care settings
RCT to Evaluate an Implementation Strategy to Increase Optimal Use of HPV Vaccine in Primary Care
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-10880314
This study is looking for ways to help doctors give the HPV vaccine to kids and teens more effectively, so they can stay healthy and avoid HPV-related cancers as they grow up.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10880314 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the administration of the HPV vaccine among children and adolescents by implementing a multi-faceted strategy in primary care. The approach includes educating healthcare providers about the importance of vaccinating patients before they become sexually active, providing feedback on vaccination rates, and improving communication skills to address parental concerns. By ensuring that the vaccine series is completed by age 13, the project seeks to significantly reduce the incidence of HPV-related cancers. The study will assess the effectiveness of these strategies in increasing vaccination rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and adolescents aged 0 to 17 years who are eligible for the HPV vaccine.
Not a fit: Patients who are already vaccinated or those outside the target age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to higher vaccination rates, ultimately reducing the risk of HPV-related cancers in the population.
How similar studies have performed: Previous research has shown that targeted interventions can effectively increase vaccination rates, suggesting that this approach may yield positive results.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KING, ALLISON A — WASHINGTON UNIVERSITY
- Study coordinator: KING, ALLISON A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: B pertussis infection, B. pertussis infection, Bordetella pertussis infection, Cancers, Centers for Disease Control